Edward White
Stock Analyst at HC Wainwright & Co.
(1.46)
# 3,441
Out of 5,182 analysts
338
Total ratings
29.97%
Success rate
-8.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $13.25 | +149.06% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $5.49 | +209.65% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $3.00 | +400.00% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $3.48 | +72.66% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $0.58 | +2,651.03% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.89 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $31.54 | +153.65% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.62 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $10.75 | +86.05% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $4.96 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $4.44 | +260.36% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $6.96 | +259.20% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.61 | +396.89% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $14.42 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $7.93 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $35.38 | +55.46% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $21.00 | +142.86% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $7.51 | -6.79% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $8.66 | +546.65% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $101 → $52 | $10.24 | +407.81% | 4 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.76 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $29.48 | +1.76% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.31 | +816.03% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $13.25
Upside: +149.06%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $5.49
Upside: +209.65%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $3.00
Upside: +400.00%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $3.48
Upside: +72.66%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $0.58
Upside: +2,651.03%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.89
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $31.54
Upside: +153.65%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.62
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $10.75
Upside: +86.05%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.96
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $4.44
Upside: +260.36%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $6.96
Upside: +259.20%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $1.61
Upside: +396.89%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $14.42
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $7.93
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $35.38
Upside: +55.46%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $21.00
Upside: +142.86%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $7.51
Upside: -6.79%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $8.66
Upside: +546.65%
Aug 5, 2022
Downgrades: Neutral
Price Target: $101 → $52
Current: $10.24
Upside: +407.81%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.76
Upside: -
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $29.48
Upside: +1.76%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.31
Upside: +816.03%